Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
Frank Hilberg(Boehringer Ingelheim (Germany)), Norbert Kraut(Boehringer Ingelheim (Austria))
Cited by 105